Mastercard and the Medical Tourism Association join forces to revolutionize cross-border healthcare payments →
Dr. Panayotis Kaloyannidis has joined Burjeel Medical City as Specialist Hematologist in the Adult Hematology and Bone Marrow Transplant department. He has 25 years of experience, mainly in the field of malignant hematological diseases and their treatment with conventional chemotherapy and cellular therapies, including hemopoietic stem cell transplantation. Since 1998 he has been actively involved in more than 2000 hematopoietic stem cell transplants (autologous and allogeneic) from any source of hematopoietic cells (bone marrow, peripheral blood, and umbilical cord blood). In 2012-2013 he was trained in cellular therapies with chimeric antigen receptors T cells (CAR T-cells) and specific T-cells against viral infections and relapse post allogeneic stem cell transplantation. His Expertise and areas of interest include diagnosis and treatment of malignant hematological diseases, hematopoietic stem cell transplantation, post-transplantation complications (Graft vs. Host disease, infections, relapsed disease), cellular therapies, and immunotherapy for malignant hematological diseases. Dr. Kaloyannidis has held a senior Consultant Hematologist position at the Department of Hematology and Bone Marrow Transplantation Unit at the “G. Papanicolaou” General Hospital in Thessaloniki, Greece, from 1998-2014 and as a senior Consultant Hematologist at the Adult Oncology/Hematology and SCT department at King Fahad Specialist Hospital-Dammam, S. Arabia from June 2014- March 2023. Dr. Kaloyannidis is a member of the Hellenic Society of Hematology, the European Society for Bone Marrow Transplantation (EBMT), and the Saudi Society of Blood and Marrow Transplantation (SSBMT). His areas of expertise include,
.png)
